OTC Colon Cancer Screening Test Now Available in Pharmacies Across US
Drug Topics
FEBRUARY 27, 2024
Reese Pharmaceutical’s ColoTest has a suggested retail price of $19.99 and will also be sold on major retail shelves later this spring.
Tue.Feb 27, 2024
201 
Cholera vaccine shortage reaches worst point yet, with experts fearing deadly outbreaks
STAT
FEBRUARY 27, 2024
An unprecedented shortage of cholera vaccine has public health experts fearing that a recent surge of outbreaks across developing countries will only worsen, a situation they argue is as regrettable as it was avoidable. At least 16 countries in Asia, Africa, and the Caribbean are dealing with cholera outbreaks. According to the latest report from the European Centre for Disease Prevention and Control , between Dec. 23 and Jan. 23, nearly 50,500 people contracted cholera and nearly 500 died.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Know Labs Announces Wearable, Non-Invasive Continuous Glucose Monitor
Drug Topics
FEBRUARY 27, 2024
If approved, KnowU will become the world’s first non-invasive blood glucose monitor introduced to the global marketplace.
STAT+: FTC says pharmacy benefit managers are stonewalling requests for information
STAT
FEBRUARY 27, 2024
A much-anticipated inquiry by U.S. antitrust regulators into pharmaceutical industry middlemen has been stymied because the companies have failed to provide many of the documents that, in some cases, were requested as far back as June 2022. The inquiry was begun by the Federal Trade Commission in response to the role that pharmacy benefit managers play in the cost of prescription medicines.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
ViVE 2024: Veradigm buys ScienceIO in $140M deal to build out healthcare AI solutions
Fierce Healthcare
FEBRUARY 27, 2024
LOS ANGELES — Healthcare data and tech company Veradigm is picking up ScienceIO in a $140 million deal to build out large language models for healthcare. | Veradigm plans to use the company's platform to create its own proprietary large language models on its own massive dataset, which includes 400,000 providers and over 200 million patients.
Opinion: IVF bans like Alabama’s could cost the lives of children already born
STAT
FEBRUARY 27, 2024
When my wife, Laurie, completed her ninth in vitro fertilization cycle in the spring of 2000, we had more than 150 fertilized embryos in frozen storage at the Center for Reproductive Medicine and Infertility at the NewYork Presbyterian Hospital-Weill Medical College of Cornell University. We were not stockpiling them for later use. At the time, our son Henry was 5.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Protocols originally intended to be extra conservative are now heralded as evidence of mifepristone’s risk
STAT
FEBRUARY 27, 2024
Decisions made by the Food and Drug Administration more than 20 years ago have come under heightened scrutiny thanks to a lawsuit calling for increased restrictions around the pregnancy-terminating drug mifepristone. The Alliance of Hippocratic Medicine, a recently formed umbrella organization composed of several anti-abortion groups, has argued the protocols first adopted to safeguard mifepristone are indicative of the drug’s danger.
Perrigo plots hundreds of job cuts as it embarks on restructuring initiative
Fierce Pharma
FEBRUARY 27, 2024
Over-the-counter self-care specialist Perrigo is poised to leave hundreds of workers by the wayside as it embarks on the next leg of its corporate journey. | As part of a cost-cutting and restructuring initiative dubbed "Project Energize," Perrigo expects to trim roughly 6% of its total staff, the company said in a fourth-quarter earnings release Tuesday.
STAT+: Viking Therapeutics obesity drug hits target in key study, raising hopes for a competitor to existing medicines
STAT
FEBRUARY 27, 2024
An obesity medication from Viking Therapeutics succeeded in a Phase 2 clinical study, the company said Tuesday, helping patients lose up to nearly 15% of their weight over about three months and further fueling the competition in the exploding obesity drug market. Shares of the San Diego-based company doubled in premarket trading. The trial tested four different weekly injectable doses of the Viking drug, called VK2735, over 13 weeks, with patients seeing a dose-dependent amount of
Nearly all doctors suffer burnout, survey finds, but many cautiously hopeful that AI could help
Fierce Healthcare
FEBRUARY 27, 2024
Nearly all physicians in the U.S. | Nearly all physicians in the U.S. said they feel regularly burned out and over half of them have considered either leaving the profession or adopting non-patient-facing roles, according to a new Athenahealth survey.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
GSK pill works in uncomplicated gonorrhea
STAT
FEBRUARY 27, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi. Hello. It’s Meghana. Today we’re excited to unveil the 2024 STATUS List , a rundown of the 50 most influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech.
Why is pharma going gaga for radiopharmaceuticals?
pharmaphorum
FEBRUARY 27, 2024
Pharmaceutical companies are increasingly focusing on radiopharmaceuticals due to their potential in oncology and therapeutic applications. Learn more about why the industry is excited about radioisotopes in this article.
Opinion: Palliative psychiatry offers a new path for some people with serious mental illness
STAT
FEBRUARY 27, 2024
The Canadian surgeon and urologist Balfour Mount is considered the father of palliative care in North America. He was inspired and mentored by Cicely Saunders, a British nurse and social worker. Before she became a physician, Saunders developed the first modern hospice , St Christopher’s in London in 1967. Mount adapted and transplanted approaches to the care of the terminally ill he had learned at St Christopher’s to the Royal Victoria Hospital in Montreal.
Industry Pharmacists Organization (IPhO) Releases a New Report Summarizing the Current State of Pharmacist Job Satisfaction
Drug Topics
FEBRUARY 27, 2024
Survey data from nationally conducted studies of pharmacist practice settings including community, health system, and clinical pharmacy are consistently showing between 40-60% reporting job dissatisfaction and/or burnout
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Alignment Healthcare to eliminate ACO REACH exposure, exceeds revenue expectations
Fierce Healthcare
FEBRUARY 27, 2024
Insurtech Alignment Healthcare has recorded $1.82 billion in revenue for full-year 2023 and beat market expectations for quarterly revenue by more than $20 million, the company announced Feb. | Alignment Healthcare stressed it should reach profitability this year and announced it would pulling back from the ACO REACH program, the company said during a fourth-quarter earnings call.
Biktarvy Indication Expanded by FDA for Resistant HIV
Drug Topics
FEBRUARY 27, 2024
The new approval is supported by the phase 3 Study 4030, which evaluated the efficacy, safety, and tolerability profile of Biktarvy in a broad range of people with HIV-1 with or without pre-existing NRTI resistance, including those with the M184V/I resistance.
Accelerating the process, transforming therapies and advancing precision medicine
pharmaphorum
FEBRUARY 27, 2024
Next-generation technology is enabling drug discovery at an entirely new scale, accelerating the process, transforming therapies and advancing precision medicine, and resulting in better patient outcomes. In this podcast, Dr Mohit Jain, founder and CEO of Sapient, discusses personalised disease prediction, diagnostics, and therapies.
One Up, One Down: Allecra scores FDA nod for antibiotic combo after Venatorx hit with rejection
Fierce Pharma
FEBRUARY 27, 2024
Over the last few days, as the FDA rejected one antibiotic combination treatment for complicated urinary tract infections (cUTIs), it has approved another. | Over the last few days, as the FDA rejected one antibiotic combination treatment for complicated urinary tract infections (cUTIs), it has approved another. The U.S. regulator has signed off on Allecra Therapeutics’ Exblifep as a treatment for cUTIs, including the severe kidney condition pyelonephritis.
FDA says yes to Allecra, no to Venatorx UTI drugs
pharmaphorum
FEBRUARY 27, 2024
The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product from Venatorx.
Cosnova Beauty sets its sights on growth in 2024
Drug Store News
FEBRUARY 27, 2024
DSN spoke to Cosnova founder Christina Oster-Daum and Jill Krakowski, chief marketing officer, USA, about the company’s growth, plans for the year ahead and how social media has played a key role in the popularity of its brands.
PE-backed anesthesiology group ends contracts with 5 Colorado hospitals, phases out non-competes to resolve monopoly inquiry
Fierce Healthcare
FEBRUARY 27, 2024
PE-backed anesthesiology group ends contracts with 5 Colorado hospitals, phases out non-competes to resolve monopoly inquiry dmuoio Tue, 02/27/2024 - 15:40
iA launches shared central fulfillment solution
Drug Store News
FEBRUARY 27, 2024
iA’s NEXiA software now enables central fill operations with the ability to monetize excess capacity within a central fulfillment operation while providing operations across multiple pharmacy providers.
Europe’s commercial leaders prepare for a faster trial-to-treatment pathway
pharmaphorum
FEBRUARY 27, 2024
Europe's commercial leaders are gearing up for a faster trial-to-treatment pathway, leveraging CRM technology to empower HCPs and sales teams.
Food Lion Feeds partners with CIAA Schools to address food insecurity
Drug Store News
FEBRUARY 27, 2024
Food Lion Feeds is helping provide nonperishable food to eight Historically Black Colleges and Universities that are part of the Central Intercollegiate Athletic Association.
Amgen opens its most advanced manufacturing facility to date
European Pharmaceutical Review
FEBRUARY 27, 2024
Amgen has opened a new biomanufacturing plant in Central Ohio, US. It is the company ’s most advanced manufacturing facility to date. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen. “As part of Amgen’s global biomanufacturing network, Amgen Ohio will play an important role in helping us
Looking to the future of clinical trials: Gene therapy, precision medicine, and the ongoing quest for rare disease solutions
pharmaphorum
FEBRUARY 27, 2024
Looking to the future of clinical trials: Gene therapy, precision medicine, and the ongoing quest for rare disease solutions Mike.
What are the best blood pressure medications for erectile dysfunction?
The Checkup by Singlecare
FEBRUARY 27, 2024
You might not know that ED (erectile dysfunction) is associated with other health issues—like high blood pressure (also known as hypertension). In a SingleCare survey , high blood pressure was reported or believed to be the most common physical cause of ED. High blood pressure medications can sometimes alleviate erectile dysfunction by reducing stress on the blood vessels and allowing more normal blood flow.
Minerva slumps as FDA finds fault with schizophrenia filing
pharmaphorum
FEBRUARY 27, 2024
FDA has turned down Minerva Neurosciences' marketing application for roluperidone as a treatment for the negative symptoms of schizophrenia
Kristin Ess’ Softening Collection caters to over processed, dry tresses
Drug Store News
FEBRUARY 27, 2024
The brand’s new Softening Collection offers four new products that not only wash but hydrate and help style strands that may otherwise be over-processed, dry or dull.
MHRA Chief Executive to step down
European Pharmaceutical Review
FEBRUARY 27, 2024
The Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine, will step down in the Autumn following five years in the role. Dame June will remain in the position until then to support the new Chief Executive’s transition into the role. Leading the MHRA – a five year journey Professor Graham Cooke, interim chair of the MHRA board, remarked that Dame June’s “leadership of the MHRA over the last five years, particularly during the COVID-19 pand
Rising Investment in Patient Support Drives a Greater Biopharma Focus on Measurement
Fierce Pharma
FEBRUARY 27, 2024
A seismic shift has occurred in the healthcare landscape. | Delivering on these heightened expectations has fueled the urgency to invest in patient engagement and support. As pharmaceutical companies' channel ever-increasing resources into these transformative initiatives, the need for robust and comprehensive measurement becomes not just an option, but an imperative, in order to validate allocation of resources and effectiveness of the investment.
Study rings warning bell over cancer therapy access in UK
pharmaphorum
FEBRUARY 27, 2024
UK cancer survival is lagging 10-15 years behind other countries due to lower rates of chemotherapy and radiotherapy, says UCL study backed by CRUK.
Organon's prolific asthma med Singulair needs new safety labeling, NY attorney general argues
Fierce Pharma
FEBRUARY 27, 2024
Organon’s inherited asthma med Singulair is back in the spotlight for the wrong reasons after New York Attorney General Letitia James raised fresh concerns about the drug’s neuropsychiatric side ef | Organon’s inherited asthma med Singulair is back in the spotlight for the wrong reasons after New York Attorney General Letitia James raised fresh concerns about the drug’s neuropsychiatric side effects—especially in kids.
UK biotech Curve swings £40.5m in Pfizer-backed round
pharmaphorum
FEBRUARY 27, 2024
UK biotech Curve Therapeutics raises $51 million in a Pfizer-led Series A that will support its platform for screening drugs within cells.
Let's personalize your content